News

To boost your preparation, we have created a complete Important Days Capsule for SBI PO Mains 2025, which includes all the major national and international days celebrated throughout the year.
What if you could lose weight with a daily pill instead of painful weekly jabs like you would with Ozempic, the injectable form of semaglutide that controls both blood sugar and obesity? US ...
To make your preparation smoother and faster, we have compiled a dedicated Appointments Capsule for SBI PO Mains Exam 2025. This PDF is designed for easy revision and can be accessed anytime, anywhere ...
It positions the pharma to dominate the oral GLP-1 market. The pill achieved 7.9% weight loss (16 pounds) and 1.3% to 1.6% A1C reduction in diabetes patients over 40 weeks, rivaling Novo Nordisk ...
Donald Trump's desire to persecute pharma companies with his illogical and unjustifiable tariffs is a particular threat to the UK. Life sciences is one of the areas in which the country still ...
Soyuz capsule lands safely in Kazakhstan, returning two Russians and one American from ISS. Crew spent 220 days in space, completing 3,520 Earth orbits; Pettit turned 70 on landing day.
A new daily weight-loss pill could be just as effective as the popular injectables that help patients lower their blood sugar and lose unwanted weight. "I think we're really at the beginning of a ...
The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.
A California biotech company has developed a new pill that could extend a dog’s life. After one year of the groundbreaking clinical trial, the pill cleared a major FDA hurdle. More than 1,000 ...
Eli Lilly's experimental oral pill, orforglipron, has shown promising results in Phase 3 trials, effectively lowering weight and blood sugar levels similar to Ozempic in diabetes patients.
A new experimental GLP-1 drug, in pill form, could transform the weight loss drug boom. Eli Lilly's new experimental pill called orforglipron, helped patients shed weight and control blood sugar ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...